Despite the fact that FLT3-ITD has long been known to associate with poor prognosis [53, 54], in the present study, co-occurrence of FLT3-ITD with RUNX1 mutation did not affect outcomes in paediatric AML, which is consistent with results in adult AML [15]. This evidence concerns the gene RUNX1 and acute myeloid leukemia.